Literature DB >> 21679744

Depressive symptoms and attenuated physiological reactivity to laboratory stressors.

Andreas Schwerdtfeger1, Ann-Kathrin Rosenkaimer.   

Abstract

There is evidence that depressive symptoms are associated with attenuated physiological reactivity to active stressors. However, it is not known whether blunted reactivity in depressed individuals is stressor-specific. We examined cardiovascular and electrodermal reactivity in non-clinical participants with varying levels of depressive symptoms to different active and passive stressors. Depressive symptoms were inversely related to both blood pressure and skin conductance reactivity during a public speaking task and the viewing of the speech video. However, no effects were found during a cold pressor task. Together these findings suggest that depressive symptoms are related to attenuated sympathetic nervous system reactivity in response to self-relevant stressors.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21679744     DOI: 10.1016/j.biopsycho.2011.05.009

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  21 in total

1.  Pre-ejection period reactivity to reward is associated with anhedonic symptoms of depression among adolescents.

Authors:  Joshua J Ahles; Amy H Mezulis; Sheila E Crowell
Journal:  Dev Psychobiol       Date:  2017-04-13       Impact factor: 3.038

2.  Lower electrodermal activity to acute stress in caregivers of people with autism spectrum disorder: an adaptive habituation to stress.

Authors:  Nicolás Ruiz-Robledillo; Luis Moya-Albiol
Journal:  J Autism Dev Disord       Date:  2015-02

3.  Anticipation of public speaking and sleep and the hypothalamic-pituitary-adrenal axis in women with irritable bowel syndrome.

Authors:  M M Heitkemper; K C Cain; W Deechakawan; A Poppe; S-E Jun; R L Burr; M E Jarrett
Journal:  Neurogastroenterol Motil       Date:  2012-04-03       Impact factor: 3.598

4.  Associations of depression severity with heart rate and heart rate variability in young adults across normative and clinical populations.

Authors:  Laura M Lesnewich; Fiona N Conway; Jennifer F Buckman; Christopher J Brush; Peter J Ehmann; David Eddie; Ryan L Olson; Brandon L Alderman; Marsha E Bates
Journal:  Int J Psychophysiol       Date:  2019-06-10       Impact factor: 2.997

Review 5.  Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system.

Authors:  Mark A Oldham; Domenic A Ciraulo
Journal:  Chronobiol Int       Date:  2014-01-07       Impact factor: 2.877

6.  Effort Deficits and Depression: The Influence of Anhedonic Depressive Symptoms on Cardiac Autonomic Activity During a Mental Challenge.

Authors:  Paul J Silvia; Emily C Nusbaum; Kari M Eddington; Roger E Beaty; Thomas R Kwapil
Journal:  Motiv Emot       Date:  2014-12-01

7.  Do depressive symptoms "blunt" effort? An analysis of cardiac engagement and withdrawal for an increasingly difficult task.

Authors:  Paul J Silvia; Zuzana Mironovová; Ashley N McHone; Sarah H Sperry; Kelly L Harper; Thomas R Kwapil; Kari M Eddington
Journal:  Biol Psychol       Date:  2016-05-09       Impact factor: 3.251

8.  Distinct effects of early-life experience and trait aggression on cardiovascular reactivity and recovery.

Authors:  Samir Rana; Phyllis C Pugh; J Michael Wyss; Sarah M Clinton; Ilan A Kerman
Journal:  Physiol Behav       Date:  2018-12-04

Review 9.  Atypical reactivity of heart rate variability to stress and depression across development: Systematic review of the literature and directions for future research.

Authors:  Jessica L Hamilton; Lauren B Alloy
Journal:  Clin Psychol Rev       Date:  2016-09-20

10.  Blood pressure hyperreactivity: an early cardiovascular risk in normotensive men exposed to low-to-moderate inorganic arsenic in drinking water.

Authors:  Julie Kunrath; Eugen Gurzau; Anca Gurzau; Walter Goessler; Elyssa R Gelmann; Thu-Trang Thach; Kathleen M McCarty; Catherine W Yeckel
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.